Elucidating the specific pharmacological mechanism of motion (MOA) of naturally occurring compounds may be complicated. Although Tarselli et al. (60) formulated the main de novo synthetic pathway to conolidine and showcased this naturally transpiring compound correctly suppresses responses to the two chemically induced and inflammation-derived pain, the pharmacologic target https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers